Study population |
1. |
Patients with radiographically confirmed osteoarthritis or selected according to American College of Rheumatology guidelines |
2. |
Age, gender, and body mass index reported and not statistically different between groups |
3. |
Efficacy assessed on a single anatomical joint (for example, knee) |
Trial design |
4. |
Randomisation |
5. |
Placebo-controlled study |
6. |
Double-blind study |
7. |
Duration of at least 3 months |
8. |
Selection of a single primary endpoint before beginning of trial |
9. |
Sample size based on power calculation |
Analysis and data presentation |
10. |
Data analysed according to the intention-to-treat principle |
11. |
Reported dropout rate not more than 25% |
12. |
Report of adverse effects |